Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

References

• Armstrong RJE, Barker R. Neurodegeneration: a failure of neuroregeneration? Lancet 2001; 358: 9288.
   Web of Science ®Google Scholar
• McDonald JW, Liu XZ, Qu Y et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999; 5: 1410–1412.
   Google Scholar
• Liu S, Stewart TJ, Howard MJ et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 2000; 97: 6126–6131.
   Google Scholar
• Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nature Neuroscience 2000; 3: 537–544.
   PubMed Web of Science ®Google Scholar
• Lindvall O. Prospects of transplantation in human degenerative disease. Trends in Neuroscience 1991; 14(8): 376–384.
   PubMed Web of Science ®Google Scholar
• Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 2001; 344: 710–719.
   Google Scholar
• Dunnett SB, Bjorklund A, Lindvall O. Cell therapy in Parkinson’s disease-stop or go? Nat Rev Neurosci 2001; 2: 365–369.
   PubMed Web of Science ®Google Scholar
• Mareschi K, Biasin E, Piacibello W et al. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86 2001: 1099–1100.
   Google Scholar
• Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000; 164: 247–256.
   Google Scholar
• Kim BJ, Seo JH, Bubien JK, Oh YS. Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuro- report 2002; 13(9): 1185–1188.
   PubMed Web of Science ®Google Scholar
• Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 2002; 15; 69(6): 908–917.
   Google Scholar
• Fukunaga A, Uchida K, Hara K et al. Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain. Cell Transplant 1999; 8(4): 435–441.
   Google Scholar
• Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neuroscience Res 2000; 61: 364–370.
   PubMed Web of Science ®Google Scholar
• Black IB, Woodbury D. Adult rat and human marrow stem cells differentiate into neurons. Blood cells, Molecules and diseases 2001; 27: 3.
   Web of Science ®Google Scholar
• Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002 6880; 416: 542–545.
   Google Scholar
• Jang Y, Jahagirdaz BN, Reinbardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002 6893; 418: 41–43.
   Google Scholar
• Zhao LR, Duan WM, Reyes M et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Experi- mental Neurology 2002; 174: 1.
   Google Scholar
• Chen J, Li Y, Wang L et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J of the Neurological Sciences 2001; 189: 1–2; 49–57.
   Google Scholar
• Jin HK, Carter JE, Huntley GW, Schumanchman EH. Intra- cerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. The J of Clinical Investigation 2002; 109, 9: 1183–1191.
   PubMed Web of Science ®Google Scholar
• Maragakis NJ, Teng YD, Kerr D et al. Transplanted neural stem cells are capable of engraftment and differentiation in transgenic mutant SOD1 mice. Soc Neurosci Abs 2000; 668: 3.
   Google Scholar
• Ende N, Weistein F, Chen R et al. Human umbilical cord blood effect on SOD mice amyotrophic lateral sclerosis. Life Sci 2000; 67: 53–59.
   Google Scholar
• Chen R, Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 2000; 31: 21–30.
   PubMedGoogle Scholar
• Garbuzova-Davis S, Willing AE, Milliken M et al. Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit. In: Amyotrophic Lateral Sclerosis and Other motor neuron disorders 2001; (4): 175–180.
   Web of Science ®Google Scholar
• Garbuzova-Davis S, Willing AE, Milliken M et al. Positive effect of transplantation of hNT neurons (NTera 2|D1 Cell-Line) in a model of familial amyotrophic lateral sclerosis. In: Experimental Neurology 2002; 174(2): 169–180.
   Google Scholar
• Vastag B. Stem cells step closer to the clinic: paralysis partially reversed in rats with ALS-like disease. JAMA 2001; 285(13): 1691–1693.
   PubMed Web of Science ®Google Scholar
• Lindvall O, Hagell P. Cell therapy and transplantation in Parkinson’s disease. Clin Chem Lab Med 2001; 39(4): 356–61.
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55: 565–569.
   Google Scholar
• Mancardi GL, Saccardi R, Filippi M et al. Autologous hemato- poietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 2001; 10; 57(1): 62–68.
   Google Scholar
• Jiang Y, Jabagivdar BN, Reinbardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; Jul4; 418 (6893): 41–49.
   Google Scholar
• Janson CG, Ramesh TM, During MJ et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001; 10: 913–915.
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
   Google Scholar
• Munsat TL. Issues in clinical trial design I: use of natural history controls in therapeutic trials. A protagonist view. Neurology 1996; 47 (Suppl 2): S96–97.
   Google Scholar